- Home
- / OWC Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
OWC Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$50 K
FY, 2016
CreditSafe Score
?
Score changed on Jun 13, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 50.0K | ||||||
| General and administrative expense | 41.4K | 231.3K | 4.9M | 1.4M | (2.0M) | (4.1M) | 2.9M |
| Operating expense total | 41.4K | 231.3K | 5.0M | 1.7M | (2.1M) | (4.6M) | 3.6M |
| EBIT | (231.3K) | (5.0M) | (1.7M) | (2.1M) | (4.6M) | ||
| EBIT margin, % | -4196.1% | ||||||
| Interest income | 94.0 | ||||||
| Interest expense | 7.6K | 15.9K | 3.2K | 491.0 | |||
| Pre tax profit | (87.4K) | (5.1M) | (1.7M) | ||||
| Net Income | (87.4K) | (318.3K) | (5.1M) | (1.7M) | (2.3M) | (4.6M) | (10.3M) |